Filters

Human ADORA2A Antibody

Human ADORA2A Antibody size: bulk 0

Price 0
Size bulk
Available sizes100ug:330, 50ug:198
Storestore in freezer for long therm or fridge for short time storage
Category Coli rec, ELISAs, e, human proteins, research antibodies
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, C, C for long term storage and for short term at + 5°, Homo sapiens sapiens), If you buy Antibodies supplied by genways bulk they should be stored frozen at - 24°, humans , ssp
Gene targetADORA2A
Short nameADORA2A Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Species Humans, Human
Alternative name sapiens adenosine A2a receptor (Antibody to), H
Alternative techniqueantibodies
Alternative to gene target ADORA2A and IDBG-2843 and ENSG00000128271 and 135, Adora2a and IDBG-162633 and ENSMUSG00000020178 and 11540, BT, Plasma membranes, identical protein binding, this GO :0001609 and G-protein coupled adenosine receptor activity and molecular function this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006171 and cAMP biosynthetic process and biological process this GO :0006909 and pha this GO cytosis and biological process this GO :0006915 and apoptotic process and biological process this GO :0006954 and inflammatory response and biological process this GO :0006968 and cellular defense response and biological process this GO :0007169 and transmembrane receptor protein tyrosine kinase signaling pathway and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007188 and adenylate cyclase-modulating G-protein coupled receptor signaling pathway and biological process this GO :0007190 and activation of adenylate cyclase activity and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007417 and central nervous system development and biological process this GO :0007596 and blood coagulation and biological process this GO :0007600 and sensory perception and biological process this GO :0008015 and blood circulation and biological process this GO :0010579 and positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019899 and enzyme binding and molecular function this GO :0042802 and identical protein binding and molecular function this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process, this GO :0001609: G-protein coupled adenosine receptor activity, this GO :0001609: G-protein coupled adenosine receptor activity and also this GO :0004930: G-protein coupled receptor activity and also this GO :0005515: protein binding and also this GO :0019899: enzyme binding and also this GO :0042802: identical protein binding, this GO :0004930: G-protein coupled receptor activity, this GO :0005515: protein binding, this GO :0019899: enzyme binding, this GO :0042802: identical protein binding, 56667 and IDBG-637272 and ENSBTAG00000016944 and 617828, adenosine A2a receptor
Identity 263
Gene ADORA2A
Long gene name adenosine A2a receptor
Synonyms gene ADORA2
Synonyms RDC8
Locus 22q11, 23
Discovery year 1991-03-11
GenBank acession X68486
Entrez gene record 135
Pubmed identfication 1662665 2541503
RefSeq identity NM_000675
Classification Adenosine receptors
Havana BLAST/BLAT OTTHUMG00000150761

Subscribe to our Newsletter